Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06484439 · ClinicalTrials.gov registry record · Early Phase 1
Controlled Trial to Determine Most Effective Post-Operative Analgesia After Third Molar Extraction
A Early Phase 1 study, sponsored by United States Naval Medical Center, San Diego.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 80
- Enrollment target
NCT06484439 is a Early Phase 1 study that has completed, run by United States Naval Medical Center, San Diego. The registered enrollment target is 80 participants.
The verdict
NCT06484439, a Early Phase 1 study, has completed, sponsored by United States Naval Medical Center, San Diego.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
This is a prospective randomized clinical trial that will investigate which post-operative medications in conjunction with a multimodal analgesia approach can most effectively control post-operative pain and reduce opioid consumption.
Interventions
- DRUG Acetaminophen
- DRUG Ketorolac
- DRUG Ibuprofen
- DRUG Oxycodone
- DRUG Hydrocodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-02-14 |
| Est. Completion | 2021-12-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06484439
The ClinicalTrials.gov registry entry for NCT06484439 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Naval Medical Center, San Diego, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Acetaminophen is the first listed.
NCT06484439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06484439 about?
NCT06484439 is a clinical study titled "Controlled Trial to Determine Most Effective Post-Operative Analgesia After Third Molar Extraction". This is a prospective randomized clinical trial that will investigate which post-operative medications in conjunction with a multimodal analgesia approach can most effectively control post-operative pain and reduce opioid consumption.
What is the current status of trial NCT06484439?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 80 participants. The study started on 2018-02-14. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT06484439?
The interventions under investigation include: Acetaminophen (DRUG), Ketorolac (DRUG), Ibuprofen (DRUG), Oxycodone (DRUG), Hydrocodone (DRUG).
Who is sponsoring clinical trial NCT06484439?
This trial is sponsored by United States Naval Medical Center, San Diego, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.